Recent perspectives in clinical development of malaria vaccines.
Where this comes from
- Record sourced from PubMed, PMID 40234440.
- Also identified by DOI 10.1038/s41467-025-58963-4 and PMC identifier 12000366.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria vaccine research has progressed significantly, with RTS,S/AS01 and R21/Matrix-M receiving WHO endorsement in 2021 / 2023. These vaccines show promise, but challenges like vaccine adherence, strain variation, and resistance persist, highlighting the need for more effective, broad-reaching interventions.